CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vcanbio Cell & Gene Engineering Corp Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vcanbio Cell & Gene Engineering Corp Ltd
No.45 Dongjiu Avenue
Airport Economic Area
Phone: +86 2258617160p:+86 2258617160 TIANJIN, TNJ  300384  China Ticker: 600645600645
Business Summary
VCANBIO CELL & GENE ENGINEERING CORP., LTD is a China-based company, principally engaged in the preparation, detection and storage of cells. The Company is also engaged in cell culture and gene detection and storage, as well as the production and sale of cytokines culture solutions, cosmetics and detection reagents. The Company conducts its businesses mainly within domestic markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board HongjiaGong 58 3/26/2022 12/3/2018
Vice Chairman of the Board, General Manager HongqiWang 60 1/15/2024 5/16/2023
Vice Chairman of the Board YongWang 56 1/15/2024 6/30/2009
11 additional Officers and Directors records available in full report.

Business Names
Business Name
600645
Shanghai Met (Group) Corporation
Shanghai Zhicheng Biological Technology Co Ltd.
Zhongyuan Union Stem Cell Bioengineering

General Information
Number of Employees: 2,209 (As of 12/31/2023)
Outstanding Shares: 467,948,890 (As of 9/30/2024)
Shareholders: 34,205
Stock Exchange: SHA
Fax Number: +86 2258617161


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024